Polypid Ltd (NASDAQ: PYPD)’s stock price has dropped by -19.29 in relation to previous closing price of 3.68. Nevertheless, the company has seen a gain of 10.00% in its stock price over the last five trading days. globenewswire.com reported 2024-12-23 that • 630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025;
Is It Worth Investing in Polypid Ltd (NASDAQ: PYPD) Right Now?
The stock has a 36-month beta value of 1.30. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PYPD is 3.22M, and at present, short sellers hold a 0.47% of that float. On December 26, 2024, the average trading volume of PYPD was 15.20K shares.
PYPD’s Market Performance
PYPD stock saw a decrease of 10.00% in the past week, with a monthly decline of -22.43% and a quarterly a decrease of -24.66%. The volatility ratio for the week is 21.59%, and the volatility levels for the last 30 days are 12.05% for Polypid Ltd (PYPD). The simple moving average for the past 20 days is -1.33% for PYPD’s stock, with a -25.50% simple moving average for the past 200 days.
Analysts’ Opinion of PYPD
Many brokerage firms have already submitted their reports for PYPD stocks, with JMP Securities repeating the rating for PYPD by listing it as a “Mkt Outperform.” The predicted price for PYPD in the upcoming period, according to JMP Securities is $14 based on the research report published on September 14, 2021 of the previous year 2021.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see PYPD reach a price target of $24. The rating they have provided for PYPD stocks is “Overweight” according to the report published on July 30th, 2021.
PYPD Trading at -9.10% from the 50-Day Moving Average
After a stumble in the market that brought PYPD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.72% of loss for the given period.
Volatility was left at 12.05%, however, over the last 30 days, the volatility rate increased by 21.59%, as shares sank -17.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.90% lower at present.
During the last 5 trading sessions, PYPD rose by +18.80%, which changed the moving average for the period of 200-days by -52.33% in comparison to the 20-day moving average, which settled at $3.02. In addition, Polypid Ltd saw -27.63% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for PYPD
The total capital return value is set at -2.83. Equity return is now at value -943.05, with -132.55 for asset returns.
The debt to equity ratio resting at 3.57. The interest coverage ratio of the stock is -25.48.
Currently, EBITDA for the company is -20.26 million with net debt to EBITDA at -0.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.00.
Conclusion
To sum up, Polypid Ltd (PYPD) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
